ResearcherUniversity of PittsburghNo recent work listed
Zhuoya Wan
Matched on ORCID iD 0000-0001-6747-7100; OpenAlex author ID A5076163679. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper
Papers 2
- Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier. Co-author DOI 10.1016/j.mattod.2022.11.008↗
- Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy. First author DOI 10.1016/j.actbio.2020.01.039↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jingjing Sun · 2 shared papers, 2020–2023 · strength 0.26
- Paper Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-ba… DOI 10.1016/j.mattod.2022.11.008↗
- Paper Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy. DOI 10.1016/j.actbio.2020.01.039↗
- Song Li · 2 shared papers, 2020–2023 · strength 0.26
- Paper Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-ba… DOI 10.1016/j.mattod.2022.11.008↗
- Paper Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy. DOI 10.1016/j.actbio.2020.01.039↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.